Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Safety and Efficacy of GV1001, a novel peptide mimicking human telomerase reverse transcriptase, for the Treatment of Moderate to Severe Alzheimer’s Disease
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 고성호 | - |
| dc.date.accessioned | 2021-08-02T09:56:57Z | - |
| dc.date.available | 2021-08-02T09:56:57Z | - |
| dc.date.issued | 2019-12-04 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/11163 | - |
| dc.title | A multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Safety and Efficacy of GV1001, a novel peptide mimicking human telomerase reverse transcriptase, for the Treatment of Moderate to Severe Alzheimer’s Disease | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | the 12th edition of Clinical Trials on Alzheimer’s Disease | - |
| dc.citation.conferencePlace | San Diego, California, USA | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 신경과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Koh, Seong-Ho
- 서울 의과대학 (DEPARTMENT OF NEUROLOGY)